FP6Individual fellowship2006–2009

MC-GARD · Genome architecture in relation to disease

FP6 — Marie Curie Actions (Human Resources and Mobility)

Duration
2006-10-01 → 2009-09-30
EU contribution
€535,174
Participants
5
Scheme
EIF

Lines connect the coordinator with its partners. CORDIS does not always give exact coordinates for projects before 2014. These points are placed at city or country level.

Results in brief

Final Activity Report Summary - MC-GARD (Genome Architecture in Relation to Disease)

The MC-GARD series of events focused on genomics by studying nuclear DNA on three architectural levels; DNA-sequence, modifications and 3D-organization. Therefore seminars, computer and laboratory training were implemented. Topics logically evolved from issues related to methodological and analytical developments, through applications in research and diagnostics, and towards a better understanding of the nuclear organisation. The timing and sequence of the conferences have invariably anticipated actual advancements in the field of genome architecture on 3 different levels. The first conference in Amsterdam started off at the sequence level of the DNA, focusing on copy number variations, aberrations and single nucleotide polymorphisms in diseases like cancer, congenital disorders and susceptibility to communicable diseases like, leprosy and tuberculosis. This was followed by a hands-on workshop in Helsinki training students in the analysis of copy number variations and aberrations and single nucleotide polymorphisms. The conference in Madrid moved on to a level focusing on non-coding and structural RNAs as well as methylomics. The second hands-on workshop in Braga was entirely computer oriented and information processing of all subjects discussed in the previous meetings incl. non-coding RNAs, methylation, copy number variations, aberrations, next generation sequencing etc. The final meeting in Edinburgh then broadened again all this linear and computer information for students back in the 3-dimesional perspective of real-life, the nucleus. In this respect we are confident that these meetings formed a complete and coherent series. Meetings brought together experts from North America and Europe to give invited lectures and junior researchers were promoted to present their own research in short talks. Other students presented posters. Both for posters and social interaction ample time was allocated throughout all the programmes. In this manner MC-GARD has helped a new generation of scientists within the European community to appreciate, understand and investigate the expanded field of human genetics for the development of clinical diagnostics. Students have built a discipline specific network and faculty further expended their networks. This was facilitated by the recurring nature of the meetings combined with the coherence and logical evolution of the subjects embarked upon. Beyond doubt, the MC-GARD series of meetings and training events have provided strong support to European research groups to develop and implement the most opportune new research and diagnostic techniques in the field of genome architecture and genomics.

Data: CORDIS, © European Union

Project objective

It is now well recognised that many human diseases, including cancer and communicable diseases, involve complex (epi-) genetic processes, composed of both hereditable and environmental factors. MC-GARD is aimed at the development of the European Research Area (ERA) and proposes three conferences and two training events. This series of events (SCF) is designed to survey the development and application of techniques for the investigation of human genome from three architectural perspectives and in relation to cancer and heritable diseases. Research in this field is rapidly expanding and will have a large impact on our understanding, prognosis and diagnosis of human disease and prevention. Recent studies of cancer (i.e. glioblastoma, breast cancer), inherited complex diseases (i.e. heart defects, mental retardation) and communicable diseases (i.e. leprosy, HIV/AIDS) have demonstrated the clinical relevance of genetic variations. Additional progresses should be anticipated, with wide-scale SNP projects combined with DNA sequence analysis of large numbers of individuals.These developments obscure the distinction between major clinical disciplines encompassing genetics, microbiology, pathology and oncology, and require cross-talk with disciplines such as genomics, epigenetics, cytology, (3-D) image analysis, bioinformatics and statistics. MC-GARD will bring together junior researchers from these diverse disciplines for interaction with leading researchers and clinicians, as well as policymakers, which will allow Europe to make a significant step forward. The societal reasons for organising the events are to further our understanding of disease susceptibility and progression, and translate new tools post-genomically into diagnostics. The conferences will also provide a venue for small to medium-size companies and encourage interdisciplinary contacts. Training events will provide early-stage researchers with hands-on experience in genomics and emerging diagnostic techniques.

Original text from CORDIS.

Participants

  • VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG.UNIVERSITY MEDICAL CENTER · AMSTERDAMCoordinatorCity levelNetherlands
  • FUNDACIÓN CENTRO NACIONAL DE INVESTIGACIONES ONCOLÓGICAS CARLOS III · MADRIDCity levelSpain
  • HELSINGIN YLIOPISTO · HELSINKIFinland
  • UNIVERSIDADE DO MINHO · BRAGAPortugal
  • UNIVERSITY OF EDINBURGH · EDINBURGHUnited Kingdom

Links

Data: CORDIS, © European Union